FDA issued a Warning Letter to Amgen, Inc. on 1/27/2014 for a later inspection.
483 Amgen Dec 2012

483 Amgen Dec 2012

Maxyne Lam FDA, Caryn Mcnab FDA, Sonia Peterson FDA$119.00 - Available Now

FDA investigators audited the Amgen - Thousand Oaks, CA, United States facility and issued inspectional observations (via FDA 483) on 12 Dec 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Dec 2012
  • Location: Thousand Oaks, United States
  • FEI: 2026154
Add To Cart